Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| XBiotech Inc.XBIT · Entity 7044 | Sr.VP Corp. Strategy & Finance | July 07, 2017 | July 11, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
XBiotech Inc.
Report date July 07, 2017 · Filed July 11, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.78 · Expires 2027-07-07 | Direct | 300,000 |
Reported balance
After 2017-07-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-07-07 · Grant · Acquired 300,000 · Balance 300,000 F1: The Options vest in 3 equal annual installments beginning on the first annual anniversary of the Grant Date (July 7, 2017). |
Filing footnotes · ownership attribution and instrument terms
F1: The Options vest in 3 equal annual installments beginning on the first annual anniversary of the Grant Date (July 7, 2017).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 07, 2017 Filed Jul 11, 2017 12:20 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantEmployee Stock Option · Derivative | 300,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001209191-17-044735 · doc4.xml · derivative · entry 1 Guzman Benjamin · CIK 0001711298 · Sr.VP Corp. Strategy & Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2027-07-07 F1 · derivative.exercise_date: The Options vest in 3 equal annual installments beginning on the first annual anniversary of the Grant Date (July 7, 2017). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.